Wednesday, January 21 2026

Browsing: Business

Gemelli Biotech to work on gastrointestinal diseases with new $19M funding (Labiotech)

Business

U.S.-headquartered Gemelli Biotech Corp, which focuses on precision diagnostics for gastrointestinal (GI) diseases, has completed a $19 million series A…

Cologuard crosses $1 billion in revenues

Business

–

Exact Sciences announced its Q2 2021 results. Here are 14 takeaways from the earnings call.

Business

–

Cologuard company expects $1.7 billion revenues in 2021: 14 Takeaways from Exact Sciences quarterly earnings call

Business

These takeaways are based on the Q1 2021 Earnings Call. Kevin Conroy, Chairman and CEO, Exact Sciences and Jeff Elliott, Chief Financial Officer, Exact Sciences made these remarks.

Exact Sciences tests 4 million people. Earns $1.5 billion

Business

Last week, Exact Sciences, announced their fourth quarter results. Here are 15 takeaways from their earnings call.

Browsing: Business

Gemelli Biotech to work on gastrointestinal diseases with new $19M funding (Labiotech)

Cologuard crosses $1 billion in revenues

Exact Sciences announced its Q2 2021 results. Here are 14 takeaways from the earnings call.

Cologuard company expects $1.7 billion revenues in 2021: 14 Takeaways from Exact Sciences quarterly earnings call

Exact Sciences tests 4 million people. Earns $1.5 billion

With AI and biomarkers, selfies could support doctors’ decision-making (Healthcare IT News)

AI-Based Ambient Scribes May Reduce Physician Documentation Time, Burnout (Gastroenterology Advisor)

ChatGPT’s AI Health-Care Push Has a Fatal Flaw (Bloomberg)

300,000 patients treated with digital gut-brain therapy and growing.

Top Insights from The Scope Forward Show 2025

Why GI Can’t Ignore the Microbiome Revolution Any Longer

Convergence in GI: Dr. Erica Barnell on AI, Biology & the Future of Diagnostics